← FDA DRUG APPROVALS

FDA ANDA · ANDA083982

PROPYLTHIOURACIL

Sponsor: SUN PHARM INDUSTRIES

APPLICATION
ANDA083982
TYPE
ANDA
ORIGINAL APPROVAL
1974-05-06
LATEST ACTION
1998-12-01
ROUTE
ORAL
DOSAGE FORM
TABLET
MARKETING STATUS
Discontinued

Products

PROPYLTHIOURACILDiscontinued
PROPYLTHIOURACIL 50MG · TABLET · ORAL

Approval history

1998-12-01Manufacturing (CMC) · Supplement 46AP
1994-12-23Manufacturing (CMC) · Supplement 45AP
1994-10-11Manufacturing (CMC) · Supplement 44AP
1992-04-03Manufacturing (CMC) · Supplement 43AP
1992-04-03Manufacturing (CMC) · Supplement 41AP
1990-06-05Labeling · Supplement 40AP
1988-10-28Labeling · Supplement 39AP
1988-02-22Manufacturing (CMC) · Supplement 38AP
1988-02-22Manufacturing (CMC) · Supplement 36AP
1988-02-22Manufacturing (CMC) · Supplement 37AP
1988-02-22Manufacturing (CMC) · Supplement 35AP
1987-04-06Manufacturing (CMC) · Supplement 34AP
1986-09-22Manufacturing (CMC) · Supplement 33AP
1985-10-08Manufacturing (CMC) · Supplement 32AP
1983-02-28Manufacturing (CMC) · Supplement 28AP
1983-02-28Manufacturing (CMC) · Supplement 27AP
1974-05-06OriginalAP
VIEW ON DRUGS@FDA ↗

Related on SPEQ

Pharma industryGMP disciplineFDA drug shortagesFDA enforcement & recalls

Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.

Weekly Briefing

Get the Weekly GxP Briefing

Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.

Read a past issue →